However, our gene-based analyses demonstrates that non-synonymous GBA variants can have a greater impact on PD risk than LRRK2. In this cohort, the more common pathogenic mutations are located in the LRRK2 gene. Here, LRRK2 is linked to late-onset Parkinson disease.